146 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
NVO Novo Nordisk A/S $47.64 $114.84B Sell
Article Searches
Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns http://www.zacks.com/stock/news/295726/diabetes-devices-market-on-a-tear-3-stocks-for-solid-returns?cid=CS-ZC-FT-295726 Mar 15, 2018 - Consider these three stocks in the rapidly-growing diabetes devices market for grand returns.
Orexigen Plummets on Filing of Chapter 11 of Bankruptcy Code http://www.zacks.com/stock/news/295546/orexigen-plummets-on-filing-of-chapter-11-of-bankruptcy-code?cid=CS-ZC-FT-295546 Mar 14, 2018 - Shares of Orexigen (OREX) have declined more than 75% of its value as the company announced that it is filing for bankruptcy.
M&A, Innovation & New Drugs to Drive Pharma Stocks http://www.zacks.com/commentary/152408/ma-innovation-new-drugs-to-drive-pharma-stocks?cid=CS-ZC--152408 Mar 08, 2018 - M&A, Innovation & New Drugs to Drive Pharma Stocks
Rule Breaker February Mailbag: Reflections on the Fool's Own ETF, Plus Some Un-Foolish Investing Woes https://www.fool.com/investing/2018/03/07/rule-breaker-february-mailbag-reflections-on-the-f.aspx?source=iedfolrf0000001 Mar 07, 2018 - Some listeners to the podcast are interested in the Fool 100 Index. Others have questions and stories that cut to the heart our investing philosophy.
4 Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio http://www.zacks.com/stock/news/294071/4-buy-ranked-large-cap-pharma-stocks-to-boost-your-portfolio?cid=CS-ZC-FT-294071 Feb 28, 2018 - Though the large-cap pharma sector struggled a little after a strong start in 2018, it is largely expected to rebound as the year progresses.
Pfizer Gets Mixed Feedback on Cancer Treatments From CHMP http://www.zacks.com/stock/news/293908/pfizer-gets-mixed-feedback-on-cancer-treatments-from-chmp?cid=CS-ZC-FT-293908 Feb 27, 2018 - CHMP recommends in favor of two hematology medicines of Pfizer (PFE) while recommending against label expansion of kidney cancer drug, Sutent.
Pharma Stock Roundup: AZN's Imfinzi Gets 2nd FDA Nod, MRK to Buy Australian Firm http://www.zacks.com/stock/news/293455/pharma-stock-roundup-azns-imfinzi-gets-2nd-fda-nod-mrk-to-buy-australian-firm?cid=CS-ZC-FT-293455 Feb 23, 2018 - Key announcements this week included the FDA approval for a second indication of AstraZeneca's (AZN) Imfinzi and an acquisition offer by Merck (MRK).
Eurozone Beats United States Again: 5 Hot Stock Picks http://www.zacks.com/stock/news/293079/eurozone-beats-united-states-again-5-hot-stock-picks?cid=CS-ZC-FT-293079 Feb 21, 2018 - 5 Europe-based stocks to buy as the region scores decade-high growth rate in 2017.
The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal http://www.zacks.com/stock/news/292909/the-zacks-analyst-blog-highlights-nordisk-tjx-cigna-regeneron-and-arcelormittal?cid=CS-ZC-FT-292909 Feb 20, 2018 - The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal
Top Research Reports for Novo Nordisk, TJX Companies & Cigna http://www.zacks.com/research-daily/149587/top-research-reports-for-novo-nordisk-tjx-companies-cigna?cid=CS-ZC-FT-149587 Feb 16, 2018 - Top Research Reports for Novo Nordisk, TJX Companies & Cigna

Pages: 12345678910...15

<<<Page 5>